Blood lipids and prostate cancer: a Mendelian randomization analysis (Q37045556)

17 August 2017

Blood lipids and prostate cancer: a Mendelian randomization analysis (English)

1 reference

17 August 2017

33

1 reference

17 August 2017

14

Kenneth Muir

1 reference

17 August 2017

11

Zsofia Kote-Jarai

1 reference

17 August 2017

32

Lisa Cannon-Albright

0 references

Johanna Schleutker

20

Johanna Schleutker

1 reference

17 August 2017

31

Cezary Cybulski

1 reference

17 August 2017

Børge G. Nordestgaard

21

Børge G Nordestgaard

0 references

Nora Pashayan

Nora Pashayan

24

0 references

Sarah J Lewis

Sarah J Lewis

41

0 references

Carolina Bonilla

Carolina Bonilla

2

0 references

Manuel R. Teixeira

Manuel R Teixeira

37

0 references

George Davey Smith

George Davey Smith

40

0 references

Jyotsna Batra

Jyotsna Batra

36

0 references

Rosalind Eeles

Rosalind Eeles

9

0 references

Richard M Martin

Richard M Martin

42

0 references

Claire M Perks

Claire M Perks

4

0 references

Graham Giles

15

Graham G Giles

1 reference

17 August 2017

25

Kay-Tee Khaw

1 reference

17 August 2017

18

Henrik Gronberg

1 reference

17 August 2017

Christopher A. Haiman

19

Christopher A Haiman

1 reference

17 August 2017

23

David Neal

1 reference

17 August 2017

17

Fredrik Wiklund

1 reference

17 August 2017

28

Stephen Thibodeau

1 reference

17 August 2017

13

Sara Benlloch

1 reference

17 August 2017

35

Radka Kaneva

1 reference

17 August 2017

22

Ruth C Travis

1 reference

17 August 2017

26

Janet L Stanford

1 reference

17 August 2017

10

Doug Easton

1 reference

17 August 2017

39

Hardev Pandha

1 reference

17 August 2017

27

William J Blot

1 reference

17 August 2017

30

Adam S Kibel

1 reference

17 August 2017

Caroline J Bull

1

1 reference

17 August 2017

Jeff M P Holly

3

1 reference

17 August 2017

Neil Davies

5

1 reference

17 August 2017

Philip Haycock

6

1 reference

17 August 2017

Oriana Hoi Yun Yu

7

1 reference

17 August 2017

J Brent Richards

8

1 reference

17 August 2017

Ali Amin Al Olama

12

1 reference

17 August 2017

Robert J MacInnis

16

1 reference

17 August 2017

Christiane Maier

29

1 reference

17 August 2017

Jong Park

34

1 reference

17 August 2017

Agnieszka Micheal

38

1 reference

17 August 2017

PRACTICAL consortium

43

1 reference

17 August 2017

language of work or name

English

0 references

publication date

19 March 2016

1 reference

17 August 2017

1 reference

17 August 2017

5

1 reference

17 August 2017

1125-1136

1 reference

17 August 2017

6

1 reference

Statin Use at the Time of Initiation of Androgen Deprivation Therapy and Time to Progression in Patients With Hormone-Sensitive Prostate Cancer

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4924371

Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4924371

Cholesterol Levels in Blood and the Risk of Prostate Cancer: A Meta-analysis of 14 Prospective Studies

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4924371

HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4924371

Shared common variants in prostate cancer and blood lipids

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4924371

Mendelian randomization of blood lipids for coronary heart disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4924371

Statins: protectors or pretenders in prostate cancer?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4924371

Mendelian randomization analysis with multiple genetic variants using summarized data

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4924371

Discovery and refinement of loci associated with lipid levels

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4924371

Common variants associated with plasma triglycerides and risk for coronary artery disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4924371

Statin use and risk of prostate cancer: a meta-analysis of observational studies

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4924371

The importance of LDL and cholesterol metabolism for prostate epithelial cell growth

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4924371

The differential effects of statins on the metastatic behaviour of prostate cancer.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4924371

Cohort profile: the 'children of the 90s'—the index offspring of the Avon Longitudinal Study of Parents and Children

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4924371

Cholesterol and the risk of grade-specific prostate cancer incidence: evidence from two large prospective cohort studies with up to 37 years' follow up

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4924371

Genetic variants influencing circulating lipid levels and risk of coronary artery disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4924371

Biological, clinical and population relevance of 95 loci for blood lipids

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4924371

Men with low serum cholesterol have a lower risk of high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4924371

A flexible and accurate genotype imputation method for the next generation of genome-wide association studies

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4924371

Simvastatin inhibits the proliferation of human prostate cancer PC-3 cells via down-regulation of the insulin-like growth factor 1 receptor

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4924371

Do the cholesterol-lowering properties of statins affect cancer risk?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4924371

Multiple newly identified loci associated with prostate cancer susceptibility

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4924371

Mendelian randomization: can genetic epidemiology help redress the failures of observational epidemiology?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4924371

Mendelian randomization as an instrumental variable approach to causal inference

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4924371

Statin drugs and risk of advanced prostate cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4924371

Statins and risk of cancer: a systematic review and metaanalysis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4924371

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4924371

Mendelian randomization: prospects, potentials, and limitations

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4924371

‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease?*

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4924371

Statin effects beyond lipid lowering--are they clinically relevant?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4924371

Effects of life-style modification on serum lipids

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4924371

Risk scores of common genetic variants for lipid levels influence atherosclerosis and incident coronary heart disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4924371

Use of allele scores as instrumental variables for Mendelian randomization

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4924371

Type 2 diabetes and risk of prostate cancer: a meta-analysis of observational studies.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4924371

EAU guidelines on prostate cancer

4 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26992435

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Plasma total, LDL, and HDL cholesterol and risk of aggressive prostate cancer in the Cancer Prevention Study II Nutrition Cohort

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26992435

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1002/CAM4.695

1 reference

17 August 2017

1 reference

17 August 2017

1 reference